Skip to main content
. 2019 Oct 15;2019:1274790. doi: 10.1155/2019/1274790

Table 3.

Comparison of the primary outcomes involving VAS score, Constant score, ASEA score, and the ROM of various directions.

Time phases Included studies Chi I 2 (%) Z P
Pain by VAS score
 Baseline ①, ②, ③, ④, ⑤, ⑦, ⑧, ⑨ 5.57 0 1.69 0.09
 2 to 3 weeks ②, ④, ⑦, ⑧ 0.65 0 2.42 0.02
 4 to 6 weeks ①, ②, ④, ⑦, ⑧, ⑨ 7.02 29 0.00 1.00
 8 to 12 weeks ①, ②, ③, ④, ⑤, ⑦, ⑧, ⑨ 6.66 0 0.80 0.42
 16 to 24 weeks ①, ⑤, ⑦, ⑨ 4.64 35 0.08 0.93

Constant score
 Baseline ①, ②, ⑤, ⑧ 2.18 0 0.60 0.55
 2 to 3 weeks ②, ⑧ 0.04 0 1.11 0.27
 4 to 6 weeks ①, ②, ⑤, ⑧ 0.88 0 1.09 0.27
 8 to 12 weeks ①, ②, ⑤, ⑧ 5.05 41 0.57 0.57
 16 to 24 weeks ②, ⑤ 0.04 0 0.74 0.46

ASEA score
 Baseline ④, ⑦ 0.00 0 0.26 0.79
 2 to 3 weeks ④, ⑦ 2.55 61 0.92 0.36
 4 to 6 weeks ④, ⑦ 3.06 67 1.39 0.16
 8 to 12 weeks ④, ⑦ 3.19 65 1.34 0.16
 16 to 24 weeks

Forward flexion
 Baseline ①, ②, ③, ④, ⑤, ⑥, ⑦, ⑨ 5.43 0 0.49 0.62
 2 to 3 weeks ①, ④, ⑥, ⑨ 3.59 17 1.76 0.08
 4 to 6 weeks ①, ②, ④, ⑤, ⑥, ⑦, ⑨ 12.71 45 0.02 0.98
 8 to 12 weeks ①, ②, ③, ④, ⑤, ⑦, ⑨ 8.96 33 0.79 0.43
 16 to 24 weeks ①, ⑤, ⑦, ⑨ 2.84 0 0.13 0.90

External rotation
 Baseline ①, ②, ③, ④, ⑤, ⑥, ⑦, ⑧, ⑨ 7.11 0 0.07 0.94
 2 to 3 weeks ②, ④, ⑥, ⑦, ⑧, ⑨ 4.82 0 0.82 0.41
 4 to 6 weeks ①, ②, ④, ⑤, ⑥, ⑦, ⑧, ⑨ 13.97 49 1.67 0.09
 8 to 12 weeks ①, ②, ③, ④, ⑤, ⑦, ⑧, ⑨ 8.91 21 0.35 0.73
 16 to 24 weeks ②, ⑤, ⑦, ⑨ 1.37 0 1.83 0.07

Abduction
 Baseline ①, ②, ③, ④, ⑥, ⑧, ⑨ 4.99 0 0.63 0.53
 2 to 3 weeks ②, ④, ⑥, ⑧, ⑨ 5.63 29 1.27 0.20
 4 to 6 weeks ①, ②, ④, ⑥, ⑧, ⑨ 9.26 46 0.35 0.73
 8 to 12 weeks ①, ②, ③, ④, ⑧, ⑨ 6.41 22 1.23 0.22
 16 to 24 weeks ②, ⑨ 0.78 0 0.50 0.62

Internal rotation
 Baseline ①, ②, ③, ④, ⑤, ⑨ 9.46 47 0.57 0.57
 2 to 3 weeks ②, ④, ⑨ 0.16 0 0.32 0.75
 4 to 6 weeks ①, ②, ④, ⑤, ⑨ 1.63 0 0.14 0.89
 8 to 12 weeks ①, ②, ③, ④, ⑤, ⑨ 11.06 55 2.38 0.02
 16 to 24 weeks ②, ⑤, ⑨ 1.94 0 1.18 0.24

①Sun et al. [21], ②Goyal et al. [20], ③Khallaf et al. [22], ④Cho et al. [2], ⑤Yoon et al. [19], ⑥Ghorai et al. [18], ⑦Shin and Lee [17], ⑧Oh et al. [16], and ⑨Rizk et al. [15].